Stay updated on Anti-PD-1+Radiation in Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Anti-PD-1+Radiation in Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anti-PD-1+Radiation in Metastatic Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study record related to the safety and efficacy evaluation of anti PD-1 antibody with radiation therapy in patients with HER2-negative metastatic breast cancer.
    Difference
    0.1%
    Check dated 2024-06-06T14:42:53.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participation in the study, specifying inclusion and exclusion criteria for patients, whereas previously no information was provided about collaborators and investigators.
    Difference
    32%
    Check dated 2024-05-22T21:16:48.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:23:19.000Z thumbnail image

Stay in the know with updates to Anti-PD-1+Radiation in Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anti-PD-1+Radiation in Metastatic Breast Cancer Clinical Trial page.